Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 196 AL 210

Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence

Yousefizadeh A, Piccioni G, Saidi A, Triaca V, Mango D, Nisticò R.

Pharmacol Res. 2022 Oct;184:106404. doi: 10.1016/j.phrs.2022.106404. Epub 2022 Aug 18.

Meta-Analysis of the Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile Dementia

Wang Z, Feng Y, Wang Y, Qiu H, Rui Z, Li M, Lv L.

Comput Math Methods Med. 2022 Aug 11;2022:5046761. doi: 10.1155/2022/5046761. eCollection 2022.

Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes

Dai R, Sun Y, Su R, Gao H.

Biomed Pharmacother. 2022 Oct;154:113576. doi: 10.1016/j.biopha.2022.113576. Epub 2022 Aug 22.

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders

Assogna M, Di Lorenzo F, Martorana A, Koch G.

Biomolecules. 2022 Aug 22;12(8):1161. doi: 10.3390/biom12081161.

Exercise to Improve Postural Stability in Older Adults with Alzheimer's Disease: A Systematic Review of Randomized Control Trials

Adzhar MA, Manlapaz D, Singh DKA, Mesbah N.

Int J Environ Res Public Health. 2022 Aug 19;19(16):10350. doi: 10.3390/ijerph191610350.

The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease

Sun E, Motolani A, Campos L, Lu T.

Int J Mol Sci. 2022 Aug 11;23(16):8972. doi: 10.3390/ijms23168972.

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach

Morató X, Pytel V, Jofresa S, Ruiz A, Boada M.

Int J Mol Sci. 2022 Aug 18;23(16):9305. doi: 10.3390/ijms23169305.

Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial

Schurad B, Koch C, Schug B, Morte A, Vaqué A, De la Torre R, Iniesta M.

Curr Alzheimer Res. 2022;19(7):541-553. doi: 10.2174/1567205019666220823105059.

A systematic review on drugs for synaptic plasticity in the treatment of dementia

Piscopo P, Crestini A, Carbone E, Rivabene R, Ancidoni A, Lo Giudice M, Corbo M, Vanacore N, Lacorte E.

Ageing Res Rev. 2022 Nov;81:101726. doi: 10.1016/j.arr.2022.101726. Epub 2022 Aug 27.

TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications

Gu Z, Cao H, Zuo C, Huang Y, Miao J, Song Y, Yang Y, Zhu L, Wang F.

Neurobiol Dis. 2022 Oct 15;173:105855. doi: 10.1016/j.nbd.2022.105855. Epub 2022 Aug 27.

γ-Secretase as a drug target for familial Alzheimer's disease: the road less traveled

Wolfe MS.

Future Med Chem. 2022 Oct;14(19):1341-1343. doi: 10.4155/fmc-2022-0178. Epub 2022 Aug 30.

Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs

Liang Y, Wang L.

J Ethnopharmacol. 2022 Nov 15;298:115656. doi: 10.1016/j.jep.2022.115656. Epub 2022 Aug 27.

Neuroinflammation and Oxidative Stress in Alzheimer's Disease; Can Nutraceuticals and Functional Foods Come to the Rescue?

Onaolapo OJ, Olofinnade AT, Ojo FO, Onaolapo AY.

Antiinflamm Antiallergy Agents Med Chem. 2022;21(2):75-89. doi: 10.2174/1871523021666220815151559.

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease

Wu L, Xian X, Xu G, Tan Z, Dong F, Zhang M, Zhang F.

Mediators Inflamm. 2022 Aug 21;2022:7924199. doi: 10.1155/2022/7924199. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias